Stem Cells Reverse Heart Damage

This was the original promise ofstem cells when they were first discovered over twenty years ago.  Now we have a proof of principaldemonstration and we now have a working protocol.  They actually helped several victims.

We can now look forward to thereal stem cell revolution in the last five years of this decade.

You will go and be injected witha measured amount of tailored stem cells and maybe even larger doses ofuntailored stem cells in order to resolve and replace damaged tissue.  It should be that simple from the victim’sperspective.

The take home is that congestiveheart failure will become curable.  LizTaylor was a decade too soon for this life extension technique.

Recall most folks are sufferingfrom heart disease  and its relatedissues as they enter their eighties.

Stem cells reverse damage in enlarged hearts

March 17, 2011 — 9:35pm ET | By Howard Lovy 

Having a big heart is not necessarily a good thing, if you take thephrase literally. Patients with enlarged hearts due to damage from heartattacks are lucky to be alive, yet face a lifetime of hospitalizations and medication.However, new hope for these patients comes from researchers looking into stemcell injections.

Writing in the journal Circulation Research: Journal of theAmerican Heart Association, scientists show in a small study that stem celltherapy can reverse heart damage in patients with enlarged hearts due to heartattacks. In addition, the benefits from the stem cell injections appear to bethree times better than that offered by current medical treatments, accordingto a release. Scar tissue decreased and heart function improved, the scientistsfrom the University of Miami said.

In an interview with the MiamiHerald, Joshua Hare, the study's lead author and director of the UM MedicalSchool's Interdisciplinary Stem Cell Institute, seemed pumped about the heartdevelopment.

"That's the Holy Grail, the quest the whole field has beenpursuing for close to a decade, and this is evidence we're on the righttrack," Hare told the Herald.

A participant in the small eight-person trial, Max Eaton, 68, secondedthat emotion. "I feel very grateful," Eaton told the Herald."Almost certainly, I would be deceased or in much worse shape had I nothad the opportunity to be in this program."

Hare warned that while the study, which used two different types ofbone marrow stem cells, produced exciting results, it's only the beginning. Thereare still larger-scale studies to perform, including one involving 50 to 100hospitals and many hundreds of patients before the FDA could consider approval.That will take at least five years.

No comments:

Post a Comment